Not applicableUnknownNCT04818619What this trial is testingTIGIT in Patients With Chronic Myeloid LeukemiaWho this might be right forChronic Myeloid Leukemia Assiut University 65
Testing effectiveness (Phase 2)Looking for participantsNCT03589729What this trial is testingDexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood CancersWho this might be right forAcute Myeloid LeukemiaBlast Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveBlasts 10 Percent or More of Bone Marrow Nucleated Cells+4 more M.D. Anderson Cancer Center 100
Not applicableStudy completedNCT02501330What this trial is testingSafety And Efficacy Of BosutinibWho this might be right forChronic Myelogenous Leukemia Pfizer 702
Testing effectiveness (Phase 2)Study completedNCT00006350What this trial is testingMycophenolate Mofetil, Tacrolimus, Daclizumab, and Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic CancerWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more University of Maryland, Baltimore
Large-scale testing (Phase 3)Study completedNCT00002789What this trial is testingBone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myeloid LeukemiaWho this might be right forLeukemia Fred Hutchinson Cancer Center 100
Not applicableNot Yet RecruitingNCT07454850What this trial is testingPatient Characteristics, Co-Morbidities, and Treatment Patterns in Chronic Myeloid Leukemia Patients in KuwaitWho this might be right forLeukemia, Myeloid, Chronic-Phase Novartis Pharmaceuticals 400
Large-scale testing (Phase 3)Study completedNCT01657604What this trial is testingTKI and Interferon Alpha Evaluation Initiated by the German Chronic Myeloid Leukemia Study Group - the TIGER StudyWho this might be right forChronic Myeloid Leukemia University of Jena 717
Testing effectiveness (Phase 2)Study completedNCT01839916What this trial is testingDonor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic MalignanciesWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+61 more University of Chicago 77
Not applicableLooking for participantsNCT05943522What this trial is testingAsciminib RMP StudyWho this might be right forChronic Myeloid Leukemia Novartis Pharmaceuticals 600
Large-scale testing (Phase 3)Study completedNCT00179829What this trial is testingWT1 for the Detection of Minimal Residual DiseaseWho this might be right forLeukemiaCancer Ann & Robert H Lurie Children's Hospital of Chicago 50
Testing effectiveness (Phase 2)Study completedNCT00423514What this trial is testingClofarabine, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk and/or Advanced Hematologic Cancer or Other DiseaseWho this might be right forGraft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes Memorial Sloan Kettering Cancer Center 38
Testing effectiveness (Phase 2)Study completedNCT00357084What this trial is testingMethotrexate and Glucocorticoids in Treating Patients With Newly Diagnosed Acute Graft-Versus-Host Disease After Donor Stem Cell TransplantWho this might be right forCancer Fred Hutchinson Cancer Center 53
Testing effectiveness (Phase 2)WithdrawnNCT01652014What this trial is testingSingle or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic MalignanciesWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Lymphoblastic Leukemia in Remission+51 more University of Medicine and Dentistry of New Jersey
Post-approval studies (Phase 4)Study completedNCT03332511What this trial is testingEfficacy and Safety of Nilotinib in CML-CPWho this might be right forChronic Myeloid Leukemia, Chronic Phase Seoul National University Hospital 110
Not applicableStudy completedNCT04089839What this trial is testingDasatinib Management Among CP-CML (Chronic Phase, Chronic Myeloid Leukemia) Participants Initiating Dasatinib in a Real Life SettingWho this might be right forChronic Myeloid Leukemia Bristol-Myers Squibb 177
Testing effectiveness (Phase 2)Study completedNCT00866736What this trial is testingDasatinib in Patients With Imatinib Resistant or Intolerant Chronic Myeloid LeukemiaWho this might be right forChronic Myeloid Leukemia Kanto CML Study Group 65
Early research (Phase 1)Study completedNCT06697899What this trial is testingTGRX-678 Phase I Oral Pharmacokinetic StudyWho this might be right forChronic Myeloid Leukemia Shenzhen TargetRx Co., Ltd. 76
Very early researchUnknownNCT03228303What this trial is testingNilotinib Versus Imatinib in Treatment of Patients With Newly Diagnosed Chronic Myeloid LeukemiaWho this might be right forChronic Myeloid Leukemia Assiut University 100
Early research (Phase 1)Ended earlyNCT00674427What this trial is testingTrial of Donor Lymphocyte Infusion (DLI) and Activated DLI Following Relapse After Allogeneic Stem Cell TransplantWho this might be right forChronic Myelogenous LeukemiaAcute Myelogenous LeukemiaAcute Lymphoblastic Leukemia+5 more University of Pennsylvania 13
Not applicableStudy completedNCT00248547What this trial is testingAprepitant in Preventing Nausea and Vomiting in Patients Who Are Undergoing a Stem Cell TransplantWho this might be right forCancer OHSU Knight Cancer Institute 40